XRN Company Profile and Key Details

Average 10-day trading volume of 90.68 thousand shares is below the 3-month average of 125.37 thousand, indicating normal recent market interest.

Chiron Real Estate Inc. last paid a dividend of 2.5 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Chiron Real Estate Inc. (NYSE:XRN) closed at $36.24 USD, losing -$0.07 (-0.19%) from the previous close of $36.31. The stock is currently mid-range between its 52-week high and low $29.05 and $39.93. With a market capitalization of about $484.87 million, Chiron Real Estate Inc. is classified as a small-cap and shows market-like volatility (beta ~1.20). Key stats such as the average daily volume over the past year has been around 110.03 thousand shares, volume is running light vs its 52-week average. Headquartered in Bethesda, MD, Chiron Real Estate Inc. operates in the Financial Services sector and the REIT - Industrial industry. Led by CEO Ray Braun, the company employs approximately 26 people and listed since June 19, 2016. Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and the leasing of those properties to healthcare systems and physician groups.

Chiron Real Estate Inc. trades at a P/E ratio of -83.19, slightly below the S&P 500 average, with a price-to-sales ratio of 3.07 and a price-to-book ratio of 0.95 suggesting the stock is closer to book value. The P/FCF stands at 6.92, also below market averages.

Valuation shows Chiron Real Estate Inc. trading at a premium to the broader market with a P/E of -83.19. Our AI forecast model points to short-term strength (6.22% over two weeks), a medium-term rise (20.16% over three months), and a longer-term gain (59.21% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Chiron Real Estate Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 6.22%, with price expected at $38.57 by May 01, 2026, within a range of $37.87 to $39.29 3-Month Outlook: Projected rise of 20.16%, reaching $43.63 by July 16, 2026, with a range of $43.56 to $43.70. 1-Year Outlook: Projected gain of 59.21%, with price at $57.81 by April 16, 2027, within a range of $57.64 to $57.98.